Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
0.5150
-0.0349 (-6.35%)
At close: Apr 1, 2025, 4:00 PM
0.5580
+0.0429 (8.34%)
After-hours: Apr 1, 2025, 4:38 PM EDT

Indaptus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
8.118.768.595.210.94
Upgrade
Research & Development
7.257.626.322.522.66
Upgrade
Operating Expenses
15.3716.3814.917.733.6
Upgrade
Operating Income
-15.37-16.38-14.91-7.73-3.6
Upgrade
Other Non Operating Income (Expenses)
0.340.960.590.020.02
Upgrade
Pretax Income
-15.02-15.42-14.32-7.71-3.58
Upgrade
Net Income
-15.02-15.42-14.32-7.71-3.58
Upgrade
Net Income to Common
-15.02-15.42-14.32-7.71-3.58
Upgrade
Shares Outstanding (Basic)
98842
Upgrade
Shares Outstanding (Diluted)
98842
Upgrade
Shares Change (YoY)
11.36%1.68%101.98%110.35%165.44%
Upgrade
EPS (Basic)
-1.61-1.84-1.73-1.89-1.84
Upgrade
EPS (Diluted)
-1.61-1.84-1.73-1.89-1.84
Upgrade
Free Cash Flow
-12.32-13.41-13.08-11.29-3.32
Upgrade
Free Cash Flow Per Share
-1.32-1.60-1.58-2.76-1.71
Upgrade
EBITDA
-15.37-16.38-14.91-7.73-3.6
Upgrade
D&A For EBITDA
00000
Upgrade
EBIT
-15.37-16.38-14.91-7.73-3.6
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q